Drug Database
Back to search

Japan· JP-3959424D1023

パビナフスプ　アルファ（遺伝子組換え）

A pabinafusp alfa product containing パビナフスプ アルファ（遺伝子組換え）, registered in Japan by ＪＣＲファーマ, on the national reimbursement list.

On Japan’s NHI price listATC A16AB27

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedパビナフスプ　アルファ（遺伝子組換え）ATCA16AB27REGISTER NO.JP-3959424D1023PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about パビナフスプ アルファ（遺伝子組換え）Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)
Active substance
パビナフスプ アルファ（遺伝子組換え）
Manufacturer
ＪＣＲファーマ
Country
Japan (JP)
ATC code
A16AB27
ATC class
Pabinafusp alfa
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b506064d-a1fa-498f-b9f1-ed8fdc6326d5
GET /v1/drugs/b506064d-a1fa-498f-b9f1-ed8fdc6326d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１０ｍｇ１瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3959424D1023",
  "category": "注射薬",
  "price_yen": 251030,
  "generic_name": "パビナフスプ　アルファ（遺伝子組換え）",
  "product_name_jp": null,
  "therapeutic_class": "3959",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about pabinafusp alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console